COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 184: Articles 1831-1840  | Next

Respiratory Viral Infection Patterns in Hospitalised Children before and after COVID-19 in Hong Kong
Pun, J. C. S., Tao, K. P., Yam, S. L. S., Hon, K. L., Chan, P. K. S., Chan, A. M., Chan, R. W. Y.
10.1101/2024.06.07.24308528 — Posted: 2024-06-11
Hyperplex PCR enables the next-generation of wastewater-based surveillance systems: long-term SARS-CoV-2 variant surveillance in Sweden as a case study
Soares, R. R. G., Varg, J. E., Szabo, A., Psallida, M., Olszewski, P., Nikou, D. V., Naseem, U., Malmberg, M., Szekely, A. J.
10.1101/2024.06.10.24308715 — Posted: 2024-06-11
Vitamin D levels and COVID-19 severe pneumonia: a prospective case-control study
Cardoso, F. J., Araujo, C. A., Silva Junior, J. R., Guimaraes, A., Taveiro, M. V., Figueiroa, J. N., Alves, J. G.
10.1101/2024.06.10.24308690 — Posted: 2024-06-11
Quantum-classical hybrid approach for codon optimizationand its practical applications
Huh, J., Park, D. K., Chung, Y. K., Lee, D., Lee, J., Kim, J.
10.1101/2024.06.08.598046 — Posted: 2024-06-11
A library-on-library screen reveals the breadth expansion landscape of a broadly neutralizing betacoronavirus antibody
Ornelas, M. Y., Ouyang, W. O., Wu, N. C.
10.1101/2024.06.06.597810 — Posted: 2024-06-10
Evaluating survey techniques in wastewater-based epidemiology for accurate COVID-19 incidence estimation
Murakami, M., Ando, H., Yamaguchi, R., Kitajima, M.
10.1101/2024.06.09.24308677 — Posted: 2024-06-10
Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: a serial cross-sectional study
Bagala, I., Namuganga, J. F., Nayebare, P., Cuu, G., Katairo, T., Nabende, I., Gonahasa, S., Nassali, M., Tukwasibwe, S., Dorsey, G., Nankabirwa, J. I., Kitaka, S., Kiguli, S., Greenhouse, B., Ssewanyana, I., Kamya, M. R., Briggs, J.
10.1101/2024.06.09.24308673 — Posted: 2024-06-10
Tocilizumab Reduces Hypercoagulation in COVID-19 - Perspectives from The Coagulation and Immunomodulation Covid Assessment (Coag-ImmCovA) Clinical Trial.
Almskog, L. M., Sjostrom, A., Sunden-Cullberg, J., Taxiarchis, A., Agren, A., Freyland, S., Borjesson, M., Wikman, A., Wahlgren, C. M., Wanecek, M., van der Linden, J., Antovic, J., Lampa, J., Magnusson, M.
10.1101/2024.05.31.24308108 — Posted: 2024-06-10
Virological characteristics of the SARS-CoV-2 KP.3, LB.1 and KP.2.3 variants
Kaku, Y., Yo, M. S., Tolentino, J. E., Uriu, K., Okumura, K., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2024.06.05.597664 — Posted: 2024-06-09
Evidence for Behavioral Autorepression in Covid-19 Epidemiological Dynamics
Lewis, D. D., Pablo, M., Chen, X., Simpson, M. L., Weinberger, L.
10.1101/2024.06.07.24308626 — Posted: 2024-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).